Overview
Radioimmunoprecipitation Assay (RIPA) is a powerful tool used to measure and quantify the amount of specific proteins in biological samples. It is based on the concept of antigen-antibody binding and utilizes an antiserum containing antibodies specific to the antigen of interest. The sample is first incubated with the antiserum and then precipitated using a cation containing buffer. This allows for the targeted protein to be “pulled out” of the sample and the remaining components to be discarded. Once the antigen-antibody complex has been precipitated, it can be separated from the sample for further analysis. The Radioimmunoprecipitation Assay is a useful tool for various fields of research, such as immunology, cancer research, and drug development. It has the ability to measure extremely low concentrations of proteins and can detect proteins that are difficult to detect with other methods. Furthermore, it is used to measure changes in protein expression pattern in different conditions or after a treatment. The results of this assay can provide valuable insights into research questions and can be used to optimize therapies or diagnose diseases.